Healthcare ❯ Pharmaceuticals

Drug Development

Clinical Trials Weight Loss Drugs Oncology Clinical Research GLP-1 Drugs Market Trends Regulatory Approval Obesity Treatment Obesity Treatments Market Competition

OpenAI Acquires Orchestra Bio to Add Agentic Workflow to Rosalind

Orchestra’s agents will map program delays and surface response options to help teams turn lab findings into concrete development steps.

Securities Suit Alleges Unicycive Hid Manufacturing Oversight That Could Delay OLC Approval

Kagan and Soai Win 2026 Nobel Prize in Chemistry

Court Rules Liquidia’s Yutrepia Infringes United Therapeutics Patent

Moderna and Merck Report Positive Phase 3 Topline for Personalized Melanoma Vaccine

Iambic Therapeutics Files for Nasdaq IPO to Fund AI Cancer Pipeline

FDA Approves Isembyld for Spinal Muscular Atrophy

Novo Nordisk Teams With Anthropic to Test Claude for Drug Discovery

Novartis’ Pelacarsen Fails Phase 3 Outcome Trial

Amgen's Cash Strength Versus Moderna's mRNA Pivot

Novartis Faces Investor Backlash After Second Late‑Stage Trial Failure

iShares' Healthcare and Pharmaceuticals ETFs Share Fees as Fidelity's FHLC Undercuts Rivals

Eli Lilly Trades Near $1,160 as GLP-1 Sales and FDA Cardio Approval Drive Valuation

Teva’s Experimental Antibody Prevents Gluten‑Triggered Intestinal Damage in Mid‑Stage Celiac Trial

Engineered Suppressor tRNAs Delivered by Inhaled Nanoparticles Restore CFTR Function in Preclinical Models

FDA Expands Approval of J&J’s Imaavy to Treat Warm Autoimmune Hemolytic Anemia

GLP-1 Drugs Reshape Obesity Care

BioMarin to Buy Alesta for $275 Million to Add Oral HPP Drug

Capricor Seeks New FDA Path for Duchenne Drug After 9–3 Advisory Vote

Anvisa Registers Duvyzat for Duchenne Muscular Dystrophy